Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Not applicableStudy completedNCT06581549What this trial is testingImmune Microenvironment and Gene Expression Profiling in MesotheliomaWho this might be right forMesotheliomaMesotheliomas PleuralMesothelioma; Lung Istituto Oncologico Veneto IRCCS 125
Not applicableNot Yet RecruitingNCT07550049What this trial is testingComprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck OncologyWho this might be right forSmall Cell Lung CancerHead and Neck CancerMalignant Pleural Mesothelioma University of Kansas Medical Center 110
Testing effectiveness (Phase 2)Study completedNCT02875548What this trial is testingAssess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyWho this might be right forDiffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more Epizyme, Inc. 58
Not applicableLooking for participantsNCT06971848What this trial is testingEvaluation of Skin Tests in Biotherapy AllergiesWho this might be right forLocally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more University Hospital, Angers 70
Not applicableUnknownNCT03558932What this trial is testingIP3R Modulation by Cancer Genes in MesotheliomaWho this might be right forMalignant Mesothelioma KU Leuven 20
Early research (Phase 1)WithdrawnNCT05375825What this trial is testingPhase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing MesothelinWho this might be right forMalignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03177668What this trial is testingClinical Study of YS110 in Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Kissei Pharmaceutical Co., Ltd. 40
Not applicableWithdrawnNCT04214015What this trial is testingA Pilot Study to Explore the Role of Gut Flora in Metastatic MesotheliomaWho this might be right forMesotheliomaMesothelioma MalignantMesothelioma; Lung+4 more ProgenaBiome
Not applicableWithdrawnNCT00733252What this trial is testingOptical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWho this might be right forLung CancerMalignant MesotheliomaMetastatic Cancer+2 more Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02369198What this trial is testingMesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLCWho this might be right forMalignant Pleural MesotheliomaNon-Small Cell Lung Cancer Asbestos Diseases Research Foundation 27
Testing effectiveness (Phase 2)Study completedNCT01112293What this trial is testingAnti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural MesotheliomaWho this might be right forPleural Malignant Mesothelioma Abramson Cancer Center at Penn Medicine 14
Testing effectiveness (Phase 2)Ended earlyNCT02357147What this trial is testingStudy of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)Who this might be right forMesothelioma, Malignant Morphotek 124
Early research (Phase 1)Study completedNCT02903914What this trial is testingArginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsWho this might be right forMetastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more Incyte Corporation 260
Early research (Phase 1)Ended earlyNCT04301011What this trial is testingStudy of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsWho this might be right forSolid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+6 more Turnstone Biologics, Corp. 27
Testing effectiveness (Phase 2)Ended earlyNCT02004028What this trial is testingWindow of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma ParticipantsWho this might be right forMalignant Pleural Mesothelioma Verastem, Inc. 35
Not applicableUnknownNCT02834169What this trial is testingFrench National Registry of Rare Peritoneal Surface MalignanciesWho this might be right forRare Peritoneal Surface MalignanciesPseudomyxoma PeritoneiPeritoneal Mesothelioma+5 more Hospices Civils de Lyon 2,171
Large-scale testing (Phase 3)Study completedNCT03710876What this trial is testingEfficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Ferring Ventures Limited 53
Not applicableActive Not RecruitingNCT04028570What this trial is testingA Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural ResectionWho this might be right forMesothelioma; Lung University Health Network, Toronto 15
Testing effectiveness (Phase 2)Looking for participantsNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28